local_hospital

Region Kalmar Laen

Address
Stromgatan 13, Kalmar Domkyrkofors., 392 48 Kalmar, Sweden

Region Kalmar Län - Multidisciplinary Clinical Research Center

Region Kalmar Län is a distinguished clinical research center conducting innovative trials across multiple therapeutic areas. The center demonstrates particular expertise in perioperative medicine, women's health, and cardiovascular disease, employing both traditional randomized controlled trial designs and cutting-edge registry-based methodologies to advance patient care.

  • Anesthesia and perioperative pain management in robot-assisted urologic surgery
  • HPV vaccination and cervical cancer prevention through population-level screening programs
  • Heart failure with preserved ejection fraction (HFpEF) treatment optimization

The research portfolio reflects a commitment to patient-centered outcomes, ranging from evaluating spinal analgesia techniques in robotic-assisted laparoscopic procedures to implementing pragmatic registry-based randomized clinical trials for cardiovascular conditions. The center's involvement in public health initiatives, particularly the organized concomitant HPV vaccination and screening programs aimed at rapid elimination of cervical cancer, demonstrates its dedication to population health improvement alongside individual patient care optimization.

Site Overview

assignment
3
connected trials
corporate_fare
3
sponsors
science
15
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
3
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 188 other sites in Sweden

description
Trial volume
3
Outperforms 53% of sites
public
Therapeutic diversity
4areas
Outperforms 62% of sites
groups
Sponsor diversity
3sponsors
Outperforms 52% of sites

Therapeutic Area Benchmark — Sweden

Select a therapeutic area to compare against other sites in Sweden.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Sweden

Market Share

Country: Sweden

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Region Kalmar Laen

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Concomitant Human Papillomavirus Vaccination and Screening for Accelerated Elimination of HPV Infection and Cervical Cancer in Swedish Women Aged 23-25Region StockholmPhase IIIRecruitingNov 2024

IMP list

lock Showing 1 of 15 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Altizide1Unknown2017-11-232017-11-23

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.